Brian G.  Andrews net worth and biography

Brian Andrews Biography and Net Worth

Mr. Andrews has served as Executive Vice President, Chief Financial Officer & Treasurer since December 2020. He previously served as our Senior Vice President, Chief Financial Officer & Treasurer from May 2018, and as Treasurer since January 2013 and Vice President since November 2014. He also served as Vice President, Global Logistics and Service for CooperSurgical, a position he held from June 2017 to May 2018. Mr. Andrews previously served as Assistant Treasurer for the Company from April 2006 to December 2012. Prior to joining Cooper, he held various corporate and investment banking positions at KeyBanc Capital Markets from 2002 to 2006 and at ING Barings from 2000 to 2001. He holds a B.A. in Economics from Columbia University.

What is Brian G. Andrews' net worth?

The estimated net worth of Brian G. Andrews is at least $396,051.72 as of March 25th, 2019. Mr. Andrews owns 4,404 shares of Cooper Companies stock worth more than $396,052 as of April 26th. This net worth estimate does not reflect any other investments that Mr. Andrews may own. Additionally, Mr. Andrews receives a salary of $1,220,000.00 as CFO at Cooper Companies. Learn More about Brian G. Andrews' net worth.

How old is Brian G. Andrews?

Mr. Andrews is currently 45 years old. There are 6 older executives and no younger executives at Cooper Companies. The oldest executive at Cooper Companies is Mr. Daniel G. McBride Esq., Executive VP & COO, who is 60 years old. Learn More on Brian G. Andrews' age.

What is Brian G. Andrews' salary?

As the CFO of The Cooper Companies, Inc., Mr. Andrews earns $1,220,000.00 per year. There are 2 executives that earn more than Mr. Andrews. The highest earning executive at Cooper Companies is Mr. Albert G. White III, President, CEO & Non-Independent Director, who commands a salary of $2,910,000.00 per year. Learn More on Brian G. Andrews' salary.

How do I contact Brian G. Andrews?

The corporate mailing address for Mr. Andrews and other Cooper Companies executives is 6101 Bollinger Canyon Road Suite 500, San Ramon CA, 94583. Cooper Companies can also be reached via phone at (925) 460-3600 and via email at [email protected]. Learn More on Brian G. Andrews' contact information.

Has Brian G. Andrews been buying or selling shares of Cooper Companies?

Brian G. Andrews has not been actively trading shares of Cooper Companies during the last quarter. Most recently, Brian G. Andrews sold 19,852 shares of the business's stock in a transaction on Tuesday, September 7th. The shares were sold at an average price of $113.28, for a transaction totalling $2,248,834.56. Learn More on Brian G. Andrews' trading history.

Who are Cooper Companies' active insiders?

Cooper Companies' insider roster includes Brian Andrews (CFO), Robert Auerbach (CEO), Jody Lindell (Director), Daniel McBride (COO), Gary Petersmeyer (Director), Agostino Ricupati (SVP), Holly Sheffield (EVP), Gerard Warner, III (COO), Robert Weiss (Director), and Albert White, III (CEO). Learn More on Cooper Companies' active insiders.

Are insiders buying or selling shares of Cooper Companies?

In the last year, insiders at the medical device company sold shares 5 times. They sold a total of 375,004 shares worth more than $34,740,553.56. The most recent insider tranaction occured on March, 18th when CAO Agostino Ricupati sold 54,724 shares worth more than $5,521,104.36. Insiders at Cooper Companies own 2.0% of the company. Learn More about insider trades at Cooper Companies.

Information on this page was last updated on 3/18/2024.

Brian G. Andrews Insider Trading History at Cooper Companies

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/7/2021Sell19,852$113.28$2,248,834.56View SEC Filing Icon  
3/25/2019Sell6,592$73.32$483,325.444,404View SEC Filing Icon  
See Full Table

Brian G. Andrews Buying and Selling Activity at Cooper Companies

This chart shows Brian G Andrews's buying and selling at Cooper Companies by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Cooper Companies Company Overview

Cooper Companies logo
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific. The CooperSurgical segment focuses on family and women's health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage to health care professionals and patients worldwide. It offers surgical and office products, including endosee endometrial imaging products, fetal pillow cephalic elevation devices for use in cesarean sections, illuminated speculum products, lone star retractor systems, loop electrosurgical excision procedure products, mara water ablation systems, paragard contraceptive IUDs, point-of-care, and uterine positioning products, as well as cryostorage, such as cord blood and cord tissue storage; fertility products and services, such as fertility consumables and equipment, donor gamete services, and genomic services, including genetic testing. The company sells its products to distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals and clinics, and authorized resellers. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.
Read More

Today's Range

Now: $89.14
Low: $88.90
High: $90.13

50 Day Range

MA: $97.52
Low: $89.86
High: $102.77

2 Week Range

Now: $89.14
Low: $75.93
High: $104.07

Volume

539,617 shs

Average Volume

1,084,369 shs

Market Capitalization

$17.72 billion

P/E Ratio

60.95

Dividend Yield

N/A

Beta

0.94